Propionylcarnitine (C3) serves as a crucial diagnostic marker for congenital fatty acid oxidation disorders and an important indicator for physiological processes such as energy metabolism, mitochondrial and peroxisome β‐oxidation activity defects, insulin resistance, and metabolic disorders [57]. This evidence concerns the gene INS and Other metabolic disease.